218 Users Online
Epigenetics Drugs Market Segmented By Mechanism of Action type such as DNA methylation, Histone modification with Distribution Channel type such as Hospital Pharmacy, Retail Pharmacy, Mail Order Pharmacy
Epigenetics is a Greek term that underlines the study of cellular level or physiological characters inherited by daughter cells without disrupting any bond present in the DNA sequence. Thus, unlike genetics, in epigenetics the changes present in gene expression is noted. There are important mechanisms in epigenetics including histone modification and chromatin modelling which are characterized for clinical studies.
There are abundant types of compounds present in general which are stated as epigenetic compounds, could be epigenetic carcinogens, DNA repair epigenetics, cancer epigenetics and more. Epigenetics drugs are used to counter the dysregulation of epigenetic events that are often caused due to pathological conditions, which often leads to any disease be it neurological disorders, cancer development and metabolic disorders.
Thus, epigenetics drugs are used as a specific inhibitors for each epigenetic condition, identifying epigenetics drugs is important in drug discovery for epigenetic conditions. Epigenetics drugs reverses some of the epigenetic changes.
The global market for epigenetics drugs is expected to witness a high increment over the forecast, mainly the growth is dependent on the cases reported which is growing at an unprecedented rate. The development for epigenetics drugs in research phase also plays an important role in expanding the market size.
The global epigenetics drugs market is still in its infancy period, very few epigenetics drugs are recommended and approved for severe health conditions. The potential market valuation for epigenetics drugs is vast as compare to other technologies in work.
The application for epigenetics drugs is only for oncology conditions at the moment, and with great no. of pipelined epigenetics drugs the market is projected to expand. The epigenetics is a comparatively new field in terms of drug development and big scale manufacturers are more inclined towards the development of epigenetics drugs.
Companies such as Constellation Pharmaceuticals, GSK and Incyte are having their epigenetics drugs in clinical phase I-II trials. Respiratory diseases and Alzheimer’s disease currently is two of the most researched field for epigenetics drugs discovery. Massive investments from the pharmaceutical businesses will allow number research with expanded therapeutic epigenetics drugs in new fields.
|by Mechanism of Action
|by Distribution Channel
On the basis of regional presence, global Epigenetics Drugs market is segmented into seven key regions viz. Europe, South Asia, East Asia, North America, Oceania, Latin America and Middle East & Africa. Europe is the biggest market for epigenetics drugs due to positive healthcare facilities and pharmaceutical consumption over cancer treatment.
North America leads the epigenetics drugs market due to the presence of leading manufacturer’s and supportive healthcare facilities for such treatment. High expenditure over epigenetics drugs R&D is present in this region complimenting its projected market value. East Asia present supporting factors in their healthcare platforms which are likely to drive the market expansion of epigenetics Drugs during the forecast period.
The global market for Epigenetics Drugs market is consolidated with few players. Examples of some of the key players operating in the Epigenetics Drugs market includes Celgene Corporation, Otsuka America, Inc., Merck & Co., Inc., TopoTarget, Novartis AG and Shenzhen Chipscreen Biosciences Co., Ltd.